European Working Party on Systemic Lupus Erythematosus and European Forum on Antiphospholipid Antibodies: two networks promoting European research on autoimmunity

1 Cervera R  . European Working Party on Systemic Lupus Erythematosus: objectives and projects. Lupus 1992; 1(Suppl. 1): 29.

2 Cervera R  Khamashta MA  Font J  . Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993; 72: 113–124.

3 Cervera R  Khamashta MA  Font J  . Morbidity and mortality in systemic lupus erythematosus. A multicenter prospective study of 1000 patients. Medicine (Baltimore) 1999; 78: 167–175.

4 Cervera R  Khamashta MA  Font J  . Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 2003; 82: 299–308.

5 Galeazzi M  Morozzi G  Sebastiani GD  . Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. Clin Exp Rheumatol 1998; 16: 541–546.

6 Galeazzi M  Bellisai F  Sebastiani GD  . Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. Clin Exp Rheumatol 1998; 16: 717–720.

7 Sebastiani GD  Galeazzi M  Tincani A  . Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Scand J Rheumatol 1999; 28: 344–351.

8 Galeazzi M  Annunziata P  Sebastiani GD  . Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. J Rheumatol 2000; 27: 135–141.

9 Galeazzi M  Sebastiani GD  Tincani A  . HLA class II alleles associations of anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 2000; 9: 47–55.

10 Galeazzi M  Sebastiani GD  Morozzi G  . HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus. Correlations with clinical and autoantibody subsets. Medicine (Baltimore) 2002; 81: 169–178.

11 Sebastiani GD  Galeazzi M  Tincani A  . HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 2003; 12: 560–563.

12 Houssiau FA  Vasconcelos C  D’Cruz D  . Immunosuppressive therapy in lupus nephritis. The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002; 46: 2121–2131.

13 Houssiau FA  Vasconcelos C  D’Cruz D  . Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis. Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 2004; 50: 3934–3940.

14 Tincani A  Filippini M  Scarsi M  Galli M  Meroni PL  . European attempts for the standardization of the antiphospholipid antibodies. Lupus 2009; 18: 913–919.

15 Reber G  Schousboe I  Tincani A  . Inter-laboratory variability of anti-β2-glycoprotein I measurement. Thromb Haemost 2002; 88: 66–73.

16 Sanmarco M  Boffa M-C  . Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome. Lupus 2009; 18: 920–923.

17 Tincani A  Allegri F  Balestrieri G  . Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553–558.

18 Cervera R  Boffa M-C  Khamashta MA  Hughes GRV  . The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus 2009; 18: 889–893.

19 Cervera R;  Khamashta MA;  Shoenfeld Y;  . Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1,000 patients. Ann Rheum Dis 2008 Sep 18. [Epub ahead of print]

20 Rotar Z  Rozman B  de Groot O  . Sixth Meeting of the European Forum on Antiphospholipid Antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus 2009; 18: 53–60.

21 Bucciarelli S  Espinosa G  Cervera R  . The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. Lupus 2009; 18: 905–912.

22 Boffa M-C  Lachassinne E  Boinot C  . European registry of babies born to mothers with antiphospholipid syndrome: a result update. Lupus 2009; 18: 900–904.

23 Avčin T  Rozman B  Cimaz R  . The Ped-APS Registry: the antiphospholipid syndrome in childhood. Lupus 2009; 18: 894–899.